Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

En bloc resections for osteogenic sarcoma.

R C Marcove, G Rosen

    Cancer
    |June 15, 1980
    PubMed
    Summary
    This summary is machine-generated.

    En bloc resection combined with chemotherapy offers a viable alternative to amputation for osteogenic sarcoma. This limb-sparing surgical approach aims to improve survival rates for patients with this bone cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tracking and Assessing Oil Spill Toxicity to Aquatic Organisms: A Novel Approach.

    Environmental toxicology and chemistry·2021
    Same author

    Evaluating the efficacy of DGT to quantify copper in stormwater at end-of-pipe.

    Chemosphere·2019
    Same author

    Public Response to Suicide News Reports as Reflected in Computerized Text Analysis of Online Reader Comments.

    Archives of suicide research : official journal of the International Academy for Suicide Research·2019
    Same author

    Response to anti-PD1 therapy with nivolumab in metastatic sarcomas.

    Clinical sarcoma research·2017
    Same author

    Palliative CT-Guided Cordotomy for Medically Intractable Pain in Patients with Cancer.

    AJNR. American journal of neuroradiology·2016
    Same author

    Progress in the treatment of Ewing sarcoma: are the rumors of the demise of cytotoxic chemotherapy premature?

    Klinische Padiatrie·2015
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    Area of Science:

    • Orthopedic Oncology
    • Surgical Oncology
    • Cancer Therapeutics

    Background:

    • Amputation has been the standard curative treatment for osteogenic sarcoma.
    • Tumor proximity to joints often necessitates extensive bone and joint removal during amputation.
    • Improving survival rates, especially for distal femur lesions, is a critical challenge.

    Purpose of the Study:

    • To evaluate en bloc resection plus chemotherapy as an alternative to radical amputation for osteogenic sarcoma.
    • To assess the efficacy of limb-sparing surgery in treating osteogenic sarcoma.
    • To compare outcomes of en bloc resection with traditional amputation methods.

    Main Methods:

    • Preliminary report on 66 patients with osteogenic sarcoma undergoing en bloc resection.

    Related Experiment Videos

  • Involved sites included femur, tibia, shoulder girdle, and fibula.
  • Patients received intensive chemotherapy in conjunction with surgery.

    • Main Results:

    • En bloc resection was performed on 66 patients across various bone locations.
    • The study focused on a specific definition of osteogenic sarcoma, including telangiectatic types.
    • Amputation cure rates for patients under 21 were reported at 17%.

    Conclusions:

    • En bloc resection with chemotherapy presents a realistic alternative to amputation for osteogenic sarcoma.
    • Limb preservation is achievable without compromising cancer surgery principles.
    • Age is a significant factor in comparing cure rates for osteogenic sarcoma treatments.